Carbon C 11 martinostat
Term · Oncology and biomedicine · MLC-T-ONC-012250
A radioconjugate composed of martinostat, a histone deacetylase (HDAC) inhibitor, labeled with the positron-emitting isotope carbon C 11, with potential use in imaging via positron emission tomography (PET)/magnetic resonance imaging (MRI). Upon intravenous administration of carbon C 11 martinostat, the martinostat moiety targets and binds to HDAC on tumor cells. Upon PET/MRI imaging, this radioligand may allow for the assessment of HDAC-expressing tumor cells. HDACs, upregulated in many tumor cell types, are a family of metalloenzymes responsible for the deacetylation of chromatin histone proteins.
| Identifier | MLC-T-ONC-012250 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | [11C]martinostat; martinostat C-11; [11C]-metformin |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-012250",
"term": "Carbon C 11 martinostat",
"field": "Oncology and biomedicine",
"definition": "A radioconjugate composed of martinostat, a histone deacetylase (HDAC) inhibitor, labeled with the positron-emitting isotope carbon C 11, with potential use in imaging via positron emission tomography (PET)/magnetic resonance imaging (MRI). Upon intravenous administration of carbon C 11 martinostat, the martinostat moiety targets and binds to HDAC on tumor cells. Upon PET/MRI imaging, this radioligand may allow for the assessment of HDAC-expressing tumor cells. HDACs, upregulated in many tumor cell types, are a family of metalloenzymes responsible for the deacetylation of chromatin histone proteins.",
"synonyms": [
"[11C]martinostat",
"martinostat C-11",
"[11C]-metformin"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/carbon-c-11-martinostat/"
}
Record 4,150 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.